Lindbrook Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $15.1K | Sell |
981
-323
| -25% | -$4.97K | ﹤0.01% | 1479 |
|
|
2024
Q4 | $28.7K | Buy |
1,304
+32
| +3% | +$705 | ﹤0.01% | 1085 |
|
|
2024
Q3 | $22.9K | Sell |
1,272
-28
| -2% | -$505 | ﹤0.01% | 1219 |
|
|
2024
Q2 | $21.1K | Buy |
1,300
+319
| +33% | +$5.18K | ﹤0.01% | 1220 |
|
|
2024
Q1 | $13.8K | Hold |
981
| – | – | ﹤0.01% | 1392 |
|
|
2023
Q4 | $10.2K | Buy |
981
+352
| +56% | +$3.68K | ﹤0.01% | 1538 |
|
|
2023
Q3 | $6.42K | Hold |
629
| – | – | ﹤0.01% | 1650 |
|
|
2023
Q2 | $4.74K | Sell |
629
-157
| -20% | -$1.18K | ﹤0.01% | 1832 |
|
|
2023
Q1 | $6.96K | Hold |
786
| – | – | ﹤0.01% | 1690 |
|
|
2022
Q4 | $7.17K | Sell |
786
-66
| -8% | -$602 | ﹤0.01% | 1605 |
|
|
2022
Q3 | $7K | Buy |
852
+30
| +4% | +$246 | ﹤0.01% | 1515 |
|
|
2022
Q2 | $6K | Sell |
822
-93
| -10% | -$679 | ﹤0.01% | 1497 |
|
|
2022
Q1 | $9K | Sell |
915
-367
| -29% | -$3.61K | ﹤0.01% | 1343 |
|
|
2021
Q4 | $10K | Buy |
1,282
+801
| +167% | +$6.25K | ﹤0.01% | 1284 |
|
|
2021
Q3 | $5K | Hold |
481
| – | – | ﹤0.01% | 1263 |
|
|
2021
Q2 | $5K | Hold |
481
| – | – | ﹤0.01% | 1309 |
|
|
2021
Q1 | $6K | Hold |
481
| – | – | ﹤0.01% | 1224 |
|
|
2020
Q4 | $5K | Sell |
481
-684
| -59% | -$7.11K | ﹤0.01% | 1208 |
|
|
2020
Q3 | $10K | Sell |
1,165
-976
| -46% | -$8.38K | ﹤0.01% | 844 |
|
|
2020
Q2 | $26K | Buy |
2,141
+1,620
| +311% | +$19.7K | 0.01% | 535 |
|
|
2020
Q1 | $5K | Sell |
521
-1,222
| -70% | -$11.7K | ﹤0.01% | 1023 |
|
|
2019
Q4 | $17K | Sell |
1,743
-2,718
| -61% | -$26.5K | 0.01% | 785 |
|
|
2019
Q3 | $31K | Buy |
4,461
+1,935
| +77% | +$13.4K | 0.01% | 562 |
|
|
2019
Q2 | $23K | Buy |
2,526
+37
| +1% | +$337 | 0.01% | 648 |
|
|
2019
Q1 | $39K | Buy |
2,489
+945
| +61% | +$14.8K | 0.02% | 487 |
|
|
2018
Q4 | $23K | Buy |
+1,544
| New | +$23K | 0.01% | 566 |
|